mild/persistent asthma
Conditions
Interventions
A:Seretide + Xiaoqinglong granules
B:Seretide + Placebo
Sponsors
China National Center for Biotechnology Development
Eligibility
Sex/Gender
All
Age
18 Years to 65 Years
Inclusion criteria
Inclusion criteria: 1. 2nd or 3rd grade bronchial asthma; 2. 18-65 years; 3. TCM cold pattern criteria; 4. signed informed consent; 5. not use hormones, theophylline or beta 2 agonists in 2 weeks.
Exclusion criteria
Exclusion criteria: 1. severe persistent or intermittent attacks bronchial asthma patients; 2. less than 18 years old or over 65 years; 3.history of serious diseases, or laboratory data suggest that people with severe systemic disease ( such as liver and kidney insufficiency), mental disorder; 4.pregnant women, nursing women, allergic; 5. allergied with drugs known or experimental drugs in certain herbs; 6. has participated in other clinical trials in 4 weeks; 7. seasonal asthma, the length of treatment less than 2 months each year; 8. patients diagnosed as heat Asthma.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| asthma control; | — |
Secondary
| Measure | Time frame |
|---|---|
| asthma QOL questionaire of Juniper;integral of symptom;Asthma control test Score; | — |
Countries
China
Contacts
Public ContactQinglin Zha
Outcome results
None listed